The primary goal of Project 2 is to determine how innate immune responses impact on the entry, infection, and replication of encephalitic flaviviruses within the central nervous system (CNS). Members of the Flavivirus genus include neurotropic viruses (e.g., West Nile (WNV), Japanese encephalitis (JEV), and tickborne encephalitis viruses) that continue to spread and cause human disease in new areas of the world. Although much work has focused on understanding flavivirus replication in cells, and on defining the virulence features of strains in vivo, less is known as to how the host innate immune mediators limit entry into the CNS and controls infection of neuronal target cells. Outside the CNS, innate immune cells recognize viral pathogen associated molecular patterns (PAMPs) and respond to infection with the orchestrated release of proinflammatory cytokines, which trigger cell-intrinsic antiviral responses and the induction of adaptive immunity. Because the CNS lacks secondary lymphoid tissues and cannot initiate adaptive immune responses, it relies, in part on innate responses of resident neural cells to limit viral invasion and the extent of infection. In preliminary studies, we have determined that types I (IF Nab) and 111 (lL-28) interferons (IFNs), modulate the ability of WNV to enter and infect the CNS. Thus, systemic and local IFN responses, which occur during WNV infection, induce brain microvascular endothelial cells (BMECs) to regulate blood-brain barrier (BBB) permeability and restrict viral entry. Once encephalitic flaviviruses enter the brain, several factors likely contribute to the regional heterogeneity and cellular distribution of infection that is observed in mouse models and human autopsy specimens. We hypothesize that innate immune responses in the CNS after flavivirus infection exhibit cell- and region-specific effects that restrict viral entry, infection, and injury of neurons. We also hypothesize that non-neuronal cells in the CNS (e.g., astrocytes, oligodendrocytes, and microglia) provide critical innate cues and produce inflammatory mediators that instruct neurons in developing specific innate immune programs to control virus infection. Insight into the cell-intrinsic and cell extrinsic processes by which the host controls flavivirus infection and minimizes neuronal injury is essential for developing strategies to contain virus spread, persistence, and disease.

Public Health Relevance

Members ofthe Flavivirus genus are leading causes of epidemic encephalitis worldwide and continue to spread globally. Our experiments will assess the virus and host interface that regulates the innate immune response and controls WNV pathogenesis in the central nervous system, which will reveal novel targets for therapeutic development to suppress flavivirus infection and minimize neuronal injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI083019-08
Application #
9067904
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
8
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bekerman, Elena; Neveu, Gregory; Shulla, Ana et al. (2017) Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest 127:1338-1352
Daniels, Brian P; Jujjavarapu, Harsha; Durrant, Douglas M et al. (2017) Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest 127:843-856
Da Costa, Andreia; Garza, Esteban; Graham, Jessica B et al. (2017) Extrinsic MAVS signaling is critical for Treg maintenance of Foxp3 expression following acute flavivirus infection. Sci Rep 7:40720
Gorman, Jacquelyn A; Hundhausen, Christian; Errett, John S et al. (2017) The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity. Nat Immunol 18:744-752
Jagger, Brett W; Miner, Jonathan J; Cao, Bin et al. (2017) Gestational Stage and IFN-? Signaling Regulate ZIKV Infection In Utero. Cell Host Microbe 22:366-376.e3
Daniels, Brian P; Snyder, Annelise G; Olsen, Tayla M et al. (2017) RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation. Cell 169:301-313.e11
Li, Junwei; Baird, Madison A; Davis, Michael A et al. (2017) Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine. Nat Biomed Eng 1:
Luo, Huanle; Winkelmann, Evandro; Xie, Guorui et al. (2017) MAVS Is Essential for Primary CD4+ T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection. J Virol 91:
Tajfirouz, Deena; West, Devin M; Yin, Xiao-Tang et al. (2017) CXCL9 compensates for the absence of CXCL10 during recurrent Herpetic stromal keratitis. Virology 506:7-13
Green, Richard; Wilkins, Courtney; Thomas, Sunil et al. (2017) Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross. G3 (Bethesda) 7:1665-1682

Showing the most recent 10 out of 120 publications